Chemical inhibitors of zinc finger protein 939 can affect its function through various biochemical pathways. Phorbol 12-myristate 13-acetate (PMA) can activate protein kinase C, which in turn can phosphorylate zinc finger protein 939. This phosphorylation can inhibit the DNA-binding ability of the protein, thus inhibiting its activity. Similarly, Trichostatin A, by inhibiting histone deacetylase, can alter chromatin structure and DNA accessibility, which can inhibit the binding of zinc finger protein 939 to its DNA recognition sites. 5-Azacytidine can alter gene expression profiles by inhibiting DNA methyltransferase, impacting the expression of target genes of zinc finger protein 939. MG132, a proteasome inhibitor, can lead to the accumulation of regulatory proteins that can compete with or inhibit the function of zinc finger protein 939.
Further, PD98059, LY294002, and Wortmannin act as inhibitors of the MEK, PI3K, and PI3K/AKT pathways, respectively. PD98059 can prevent the activation of the MAPK/ERK pathway, which is known to regulate various transcription factors including zinc finger protein 939. LY294002 and Wortmannin, both PI3K inhibitors, can inhibit the AKT signaling pathway, influencing the post-translational modification of zinc finger protein 939. SB203580 and U0126, by inhibiting p38 MAPK and MEK, respectively, can affect the MAPK signaling pathway and subsequently reduce the activity of zinc finger protein 939. Y-27632, a ROCK inhibitor, can alter the phosphorylation status of proteins, including zinc finger protein 939. SP600125, as a JNK inhibitor, can disrupt the JNK signaling pathway, which regulates numerous transcription factors. Lastly, Rapamycin inhibits mTOR, a central regulator that can affect the function and activity of various proteins, including zinc finger protein 939.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is known to activate protein kinase C (PKC), which in turn can phosphorylate a broad range of target proteins, including zinc finger proteins. The phosphorylation by PKC can inhibit the DNA-binding ability of zinc finger protein 939, thus functionally inhibiting its activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By inhibiting HDAC, it can alter the chromatin structure and accessibility, potentially inhibiting the binding of zinc finger protein 939 to its DNA recognition sites, leading to functional inhibition. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical is a DNA methyltransferase inhibitor. By reducing DNA methylation, 5-Azacytidine can alter gene expression profiles, potentially impacting the expression of target genes of zinc finger protein 939, leading to its functional inhibition. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 functions as a proteasome inhibitor. By preventing the degradation of proteins, it can lead to an accumulation of regulatory proteins that may compete with or inhibit the function of zinc finger protein 939. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, PD98059 can prevent the activation of the MAPK/ERK pathway. This pathway can regulate the activity of various transcription factors, potentially including zinc finger protein 939, leading to its inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor and can inhibit the AKT signaling pathway, which might be involved in the post-translational modification of zinc finger proteins, including zinc finger protein 939, thereby inhibiting its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor can impede the MAPK signaling pathway, which is involved in the regulation of numerous transcription factors. Inhibition of this pathway could result in reduced activity of zinc finger protein 939. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, and by inhibiting the Rho/ROCK pathway, it can alter the phosphorylation status of various proteins, potentially including zinc finger protein 939, leading to its inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, by inhibiting MEK, could indirectly inhibit the function of zinc finger protein 939 by altering the expression or activity of proteins that interact with or regulate zinc finger protein 939. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 can disrupt the JNK signaling pathway, which may be involved in the regulation of zinc finger protein 939, potentially leading to its functional inhibition. | ||||||